Skip to content

Author

Fahad M. Alshabrmi

We have 6 of 97 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Design, synthesis, spectroscopic characterization, bioactivity evaluation, and computational insight of sulfachloropyridazine-based Schiff bases

A series of five novel Schiff bases (SBs) was synthesized via condensation of substituted aryl aldehydes with sulfachloropyridazine (SCPZ) and fully characterized by UV-Vis, FTIR, 1H/13C NMR, and CHNS elemental analyses. Experimental vibrational frequencies showed good agreement with density functional theory (DFT) cal...

Muhammad Wajid, Maryam Bashir, Muhammad Uzair et al. · 0 citations
Open access Aug 2026

Structure‐Based Discovery of Fumiquinazolines as Skp2–Cks1 Protein–Protein Interaction Disruptors: Mechanistic Computational Insights and Experimental Validation

Findings identify Fumiquinazoline D as an early‐stage biochemical hit for disruption of the Skp2–Cks1 interaction and as a potential scaffold for further mechanistic validation and medicinal‐chemistry investigation.

Emadeldin M. Kamel, A. A. Allam, H. Rudayni et al. · 0 citations
Aug 2026

Elucidation of HSP90AA1-directed therapeutic mechanisms of Semecarpus anacardium phytocomponents in brain tumors via network pharmacology, target interactome mapping, and molecular simulation analyses

This multi-layered computational investigation suggests that S. anacardium contains phytochemicals with computationally predicted interactions targeting HSP90AA1-associated pathways implicated in brain tumors, and identifies HSP90AA1 as a putative target for future experimental investigation for natural product-guided...

I. U. Haq, Abbas Khan, S. Saleem et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.